Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Does anyone know how much does an unmutated IGHV matter for treatment choice and for prognosis? I just received that test result today. Thx!

A MyLeukemiaTeam Member asked a question 💭
Watertown, MA
October 8
 · 
Reactions
A MyLeukemiaTeam Member

Thanks. Maybe it’s a new thing perhaps to indicate what treatment is best. I was only recently diagnosed with CLL so this is all new to me. Guess I’ll wait till next oncology appointment in a week to find out for sure.

October 11
A MyLeukemiaTeam Member

I never had any tests to determine gene problems? I did request medication after 10 months watching my tests increase each time .

October 10
MyLeukemiaTeam

Getting a new test result like that can feel overwhelming — so it's completely understandable to want to know what it means. The short answer is: IGHV mutation status does matter, but it's one piece of a bigger picture.

Having an unmutated IGHV gene is generally associated with a less favorable prognosis. Here's what that Show Full Answer

Getting a new test result like that can feel overwhelming — so it's completely understandable to want to know what it means. The short answer is: IGHV mutation status does matter, but it's one piece of a bigger picture.

Having an unmutated IGHV gene is generally associated with a less favorable prognosis. Here's what that can mean in practice:

- CLL cells with an unmutated IGHV gene tend to be more aggressive
- Higher levels of a protein called ZAP70 are often linked to unmutated IGHV, which helps CLL cells survive
- It can signal that the disease may progress more quickly than in someone with a mutated IGHV gene When it comes to treatment, doctors today pay close attention to IGHV status alongside other genetic markers like TP53 mutations. Together, these help guide which therapies are most likely to work best for a specific person.

Most people with CLL now start with targeted therapies, such as:

- BTK inhibitors (like ibrutinib or acalabrutinib)
- BCL-2 inhibitors (like venetoclax)

These targeted treatments have shown strong results even in people with unmutated IGHV, which is genuinely encouraging news.

It's really worth having a detailed conversation with your doctor about your full results — IGHV is important, but it's considered alongside your overall CLL stage, other genetic factors, and your symptoms when building a treatment plan.

October 8
A MyLeukemiaTeam Member

I take medication that uses the BTK Inhibitor which alters to white blood cells and kill the cell. Those bad cells can attack healthy organs and the nervous system. Chemo treatments can attack everything including the brain. Learn about BTK Inhibitors & BCL medications. My medication can be good for 10 to 20 years. I benefit my health by eating healthy & exercising. I was given a money grant to help pay the copayment $3400 so my cost was $0. The group Cancer United has free booklet about different cancers and medications. No charge for booklets or mail is free.

October 12

Related Questions

View All
What Is Cytogenetic Testing and How Does It Work?
How Does Leukemia Affect the Immune System?
Does Night Shift Work Increase the Risk for Leukemia?